Moleculin Biotech, Inc. Total Liabilities and Equity
Moleculin Biotech, Inc. (MBRX) had Total Liabilities and Equity of $21.09 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $21.09M.
- 2026-03-31: Liabilities and Equity $23.36M.
- 2025-12-31: Liabilities and Equity $22.13M.
- 2025-09-30: Liabilities and Equity $20.35M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $21.09M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $23.36M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $22.13M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $20.35M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $21.59M 10-Q · filed 2025-11-13 | |
| 2025-03-31 | $21.01M 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $16.93M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $23.39M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $25.57M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $30.84M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $38.22M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $39.52M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $47.12M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $51.06M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $57.42M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $65.37M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $73.25M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $78.80M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $84.09M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $88.70M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $93.53M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $99.78M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $29.03M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $27.14M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $31.38M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $25.47M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $25.23M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $30.40M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $31.85M 10-Q · filed 2019-08-16 | |
| 2019-03-31 | $21.30M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $19.59M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $20.90M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $24.07M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $24.93M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $19.48M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $20.63M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $21.25M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $20.32M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $16.39M 10-K · filed 2018-03-28 | $16.39M 10-K · filed 2017-04-03 |
| 2016-09-30 | $17.57M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $18.74M 10-Q · filed 2016-11-21 | $19.23M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $289.66K 10-Q · filed 2016-06-16 | |
| 2015-12-31 | $28.09K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |